Humana Inc. announced the pricing terms for a cash tender offer to purchase certain outstanding debt securities on November 16, 2026. The company is offering to buy back eight series of senior notes, with a maximum aggregate purchase price of $1.5 billion, subject to a specific cap on the 2031 notes.

The notes being offered, in order of acceptance priority, include the 2.150% Senior Notes due 2032, the 3.125% and 3.700% Senior Notes due 2029, the 4.875% Senior Notes due 2030, the 1.350% and 3.950% Senior Notes due 2027, the 5.375% Senior Notes due 2031, and the 5.750% Senior Notes due 2028.

The tender offer is subject to a cap of $800 million on the aggregate principal amount of the 5.375% Senior Notes due 2031. The total consideration for each series of notes is based on a reference yield and a fixed spread, determined as of 3:00 p.m. New York City time on November 16, 2026.

Holders who tender their notes will also receive accrued interest from the last interest payment date up to, but excluding, the settlement date. The offers will expire at 5:00 p.m. New York City time on November 16, 2026, with settlement expected to occur on November 18, 2026. Humana has retained Barclays Capital Inc., BofA Securities Inc., PNC Capital Markets LLC, and U.S. Bancorp Investments Inc. as dealer managers, with D.F. King & Co. Inc. serving as the tender and information agent.